Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/ceapro-inc-czo-financial-n-strategic-swot-analysis-review_en.gif)
Ceapro Inc (CZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Ceapro Inc (Ceapro) is a biotechnology company that focuses on the development and commercialization of extracts and active ingredients from oats and other renewable plant resources. The company uses its proprietary Pressurized Gas eXpanded (PGX) technology for extraction of active ingredients. The company’s extracts are used in nutraceutical, cosmeceutical, and therapeutics products for humans and animals. Ceapro’s natural active ingredients include avenanthramides, oat beta glucan, oat oil, oat peptides, oat powder and lupin peptides; and veterinary products include ear cleanse, oat shampoo and dermal complex/conditioner. The company offers products in Canada, the US, China, Germany and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.
Ceapro Inc Key Recent Developments
May 20,2021: Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Apr 22,2021: Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 03,2021: Ceapro to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 08,2021: Ceapro to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference January 8, 2021
Nov 27,2020: Ceapro reports 2020 third quarter and nine-month financial results and operational highlights
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Ceapro Inc (Ceapro) is a biotechnology company that focuses on the development and commercialization of extracts and active ingredients from oats and other renewable plant resources. The company uses its proprietary Pressurized Gas eXpanded (PGX) technology for extraction of active ingredients. The company’s extracts are used in nutraceutical, cosmeceutical, and therapeutics products for humans and animals. Ceapro’s natural active ingredients include avenanthramides, oat beta glucan, oat oil, oat peptides, oat powder and lupin peptides; and veterinary products include ear cleanse, oat shampoo and dermal complex/conditioner. The company offers products in Canada, the US, China, Germany and other countries. Ceapro is headquartered in Edmonton, Alberta, Canada.
Ceapro Inc Key Recent Developments
May 20,2021: Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Apr 22,2021: Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 03,2021: Ceapro to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 08,2021: Ceapro to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference January 8, 2021
Nov 27,2020: Ceapro reports 2020 third quarter and nine-month financial results and operational highlights
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Ceapro Inc - Key Facts
Ceapro Inc - Key Employees
Ceapro Inc - Key Employee Biographies
Ceapro Inc - Major Products and Services
Ceapro Inc - History
Ceapro Inc - Company Statement
Ceapro Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Ceapro Inc - Business Description
Business Segment: Active Ingredient Product Technology Industry
Overview
Performance
Business Segment: Cosmeceutical Industry
Overview
Performance
Geographical Segment: Canada
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Ceapro Inc - Corporate Strategy
Ceapro Inc - SWOT Analysis
SWOT Analysis - Overview
Ceapro Inc - Strengths
Ceapro Inc - Weaknesses
Ceapro Inc - Opportunities
Ceapro Inc - Threats
Ceapro Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ceapro Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 20, 2021: Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Apr 22, 2021: Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 03, 2021: Ceapro to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 08, 2021: Ceapro to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference January 8, 2021
Nov 27, 2020: Ceapro reports 2020 third quarter and nine-month financial results and operational highlights
Aug 20, 2020: Ceapro reports 2020 second quarter and six-month financial results and operational highlights
Jun 15, 2020: Ceapro announces publication of positive results for a PGX processed drug delivery system for accelerated burn wound healing
May 28, 2020: Ceapro reports 2020 first quarter financial results and highlights
Apr 16, 2020: Ceapro reports fourth quarter and full year 2019 results and highlights
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Ceapro Inc - Key Facts
Ceapro Inc - Key Employees
Ceapro Inc - Key Employee Biographies
Ceapro Inc - Major Products and Services
Ceapro Inc - History
Ceapro Inc - Company Statement
Ceapro Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Ceapro Inc - Business Description
Business Segment: Active Ingredient Product Technology Industry
Overview
Performance
Business Segment: Cosmeceutical Industry
Overview
Performance
Geographical Segment: Canada
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Ceapro Inc - Corporate Strategy
Ceapro Inc - SWOT Analysis
SWOT Analysis - Overview
Ceapro Inc - Strengths
Ceapro Inc - Weaknesses
Ceapro Inc - Opportunities
Ceapro Inc - Threats
Ceapro Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ceapro Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 20, 2021: Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Apr 22, 2021: Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 03, 2021: Ceapro to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 08, 2021: Ceapro to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference January 8, 2021
Nov 27, 2020: Ceapro reports 2020 third quarter and nine-month financial results and operational highlights
Aug 20, 2020: Ceapro reports 2020 second quarter and six-month financial results and operational highlights
Jun 15, 2020: Ceapro announces publication of positive results for a PGX processed drug delivery system for accelerated burn wound healing
May 28, 2020: Ceapro reports 2020 first quarter financial results and highlights
Apr 16, 2020: Ceapro reports fourth quarter and full year 2019 results and highlights
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Ceapro Inc, Key Facts
Ceapro Inc, Key Employees
Ceapro Inc, Key Employee Biographies
Ceapro Inc, Major Products and Services
Ceapro Inc, History
Ceapro Inc, Subsidiaries
Ceapro Inc, Key Competitors
Ceapro Inc, Ratios based on current share price
Ceapro Inc, Annual Ratios
Ceapro Inc, Annual Ratios (Cont...1)
Ceapro Inc, Annual Ratios (Cont...2)
Ceapro Inc, Interim Ratios
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ceapro Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Ceapro Inc, Key Facts
Ceapro Inc, Key Employees
Ceapro Inc, Key Employee Biographies
Ceapro Inc, Major Products and Services
Ceapro Inc, History
Ceapro Inc, Subsidiaries
Ceapro Inc, Key Competitors
Ceapro Inc, Ratios based on current share price
Ceapro Inc, Annual Ratios
Ceapro Inc, Annual Ratios (Cont...1)
Ceapro Inc, Annual Ratios (Cont...2)
Ceapro Inc, Interim Ratios
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ceapro Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Ceapro Inc, Performance Chart (2016 - 2020)
Ceapro Inc, Ratio Charts
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Ceapro Inc, Performance Chart (2016 - 2020)
Ceapro Inc, Ratio Charts
Ceapro Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ceapro Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021